A study of serum uric acid levels in patients with ischaemic stroke and its relation with hypertension and diabetes mellitus in a tertiary hospital in Goa: a cross-sectional study
DOI:
https://doi.org/10.18203/2320-6012.ijrms20231636Keywords:
Cerebrovascular accident, Stroke, Uric acidAbstract
Background: Stroke is second leading cause of mortality worldwide1 and fifth leading cause of disability-adjusted life years in India. Multiple studies show relationship of serum uric acid levels to prognosis of cardiovascular and cerebrovascular diseases. The present study aims to ascertain relationship of serum uric acid levels with ischaemic stroke and its co-morbidities, hypertension and diabetes mellitus.
Methods: The present cross-sectional study was conducted in a tertiary care hospital in Goa. 100 admitted patients with ischaemic stroke meeting the inclusion criteria were enrolled for the study. Patients were evaluated for hyperuricemia, hypertension and diabetes mellitus. The unpaired student’s t test was used for assessing association.
Results: A total of 100 patients were studied during the study period of 18 months. The mean age among males was 60.92±11.49 years and among females was 70.55±12.03 years. The mean serum uric acid levels in the patients with ischaemic stroke was 6.04±1.09 mg/dl which was significantly higher in male patients. There was a significant association between the mean serum uric acid levels and hypertension and diabetes among these patients.
Conclusions: Serum uric acid levels could be of value in identifying patients at risk of ischaemic stroke especially those with comorbidities such as diabetes and hypertension. Judiciously selecting drugs, which could produce a hypouricemic effect may play a role in preventing ischaemic stroke in such patients. Further prospective studies are needed to establish the role of serum uric acid in ischaemic stroke.
References
World Health Organization. The top 10 causes of death. World Health Organization. Geneva, Switzerland. Available at: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death. Accessed 09 April 2022.
Dandona L, Dandona R, Kumar GA, Shukla DK, Paul VK, Balakrishnan K, et al. Nations within a nation: variations in epidemiological transition across the states of India, 1990-2016 in the Global Burden of Disease Study. The Lancet. 2017;390(10111):2437-60.
O'Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet. 2016;388(10046):761-75.
Viazzi F, Antolini L, Giussani M, Brambilla P, Galbiati S, Mastriani S, et al. Serum uric acid and blood pressure in children at cardiovascular risk. Pediatrics. 2013;132(1):e93-99.
De Cosmo S, Viazzi F, Pacilli A, Giorda C, Ceriello A, Gentile S, et al. Serum uric acid and risk of CKD in type 2 diabetes. Clin J Am Soc Nephrol. 2015;10(11):1921–9.
Brand FN, McGee DL, Kannel WB, STOKES III J, Castelli WP, et al. Hyperuricemia as a risk factor of coronary heart disease: The Framingham Study. Am J Epidemiol. 1985;121(1):11-8.
Nakagawa T, Tuttle KR, Short RA, Johnson RJ. Hypothesis: fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome. Nat Clin Pract Nephrol. 2005;1(2):80-6.
Dehghan A, Van Hoek M, Sijbrands EJ, Hofman A, Witteman JC. High serum uric acid as a novel risk factor for type 2 diabetes. Diabetes Care. 200;31(2):361-2.
Sato T, Sakai K, Komatsu T, Sakuta K, Terasawa Y, Omoto S. Risk factors for infarct expansion are different between lacunar and giant lacunar infarction. Atherosclerosis. 2020;292:17-22.
Freedman DS, Williamson DF, Gunter EW, Byers T. Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I Epidemiologic Follow-up Study. Am J Epidemiol. 1995;141(7):637-44.
Nicholls A, Snaith ML, Scott JT. Effect of oestrogen therapy on plasma and urinary levels of uric acid. Br Med J. 1973;1(5851):449-51.
Matsubara K, Matsuzawa Y, Jiao S, Takama T, Kubo M, Tarui S. Relationship between hypertriglyceridemia and uric acid production in primary gout. Metabolism. 1989;38(7):698-701.
Shah H, Patange A. The study of serum uric acid levels in ischemic stroke patients. Inter J Contem Med Res. 2019;6(1):16-20.
Multidisciplinary Expert Task Force on Hyperuricemia and Related Diseases. Chinese Multidisciplinary Expert Consensus on the Diagnosis and Treatment of Hyperuricemia and Related Diseases. Chi Med J. 2017;130(20):2473.
Milionis HJ, Kalantzi KJ, Goudevenos JA, Seferiadis K, Mikhailidis DP, Elisaf MS. Serum uric acid levels and risk for acute ischaemic non-embolic stroke in elderly subjects. J Intern Med. 2005;258(5):435–41.
Foerch C, Ghandehari K, Xu G, Kaul S. Exploring gender distribution in patients with acute stroke: A multi-national approach. J Res Med Sci. 2013;18(1):10-6.
Kaur I, Khurana A, Sachdev JK, Mohan G. Evaluation of serum uric acid in acute ischaemic stroke. Inter J Advan Med. 2017;4(1):60-5.
Mehrpour M, Khuzan M, Najimi N, Motamed MR, Fereshtehnejad SM. Serum uric acid level in acute stroke patients. Med J Islam Repub Iran. 2012;26(2):66-72.
Alper Jr AB, Chen W, Yau L, Srinivasan SR, Berenson GS, Hamm LL. Childhood uric acid predicts adult blood pressure: the Bogalusa Heart Study. Hypertension. 2005;45(1):34–8.
Dyer AR, Liu K, Walsh M, Kiefe C, DR Jr J, Bild DE. Ten-year incidence of elevated blood pressure and its predictors: the CARDIA study. Coronary Artery Risk Development in (Young) Adults. J Hum Hypertens. 1999;13(1):13-21.
Forman JP, Choi H, Curhan GC. Plasma uric acid level and risk for incident hypertension among men. J Am Soc Nephrol. 2007;18(1):287-92.
Nakanishi N, Okamoto M, Yoshida H, Matsuo Y, Suzuki K, Tatara K. Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers. Eur J Epidemiol. 2003;18(6):523-30.
